Pluristem Therapeutics, Inc. has initiated the final validation steps for its new manufacturing facility, including the validation of several installation systems such as heating, ventilation and air conditioning (HVAC), water, oil free air and sterile room systems.   Zami Aberman, chairman and chief executive officer of Pluristem, said, “I am extremely proud of our team in meeting milestones for the completion of the world’s first commercial cell therapy manufacturing facility. Assu...